Assignee
ANTIGENICS INC
US·8 granted patents·4 pending applications·253 citations·filing 1998–2006
Top patents by PatentIndex Score
12 records- 0196US7858589B2Compositions of CpG and saponin adjuvants and uses thereofANTIGENICS INC·Filed 2006·Granted Dec 28, 2010·27 cites·65 claims
- 0296US6524584B2Saponin compositions and uses thereofANTIGENICS INC·Filed 2001·Granted Feb 25, 2003·73 cites·23 claims
- 0387US6645495B1Compositions of saponin adjuvants and excipientsANTIGENICS INC·Filed 1998·Granted Nov 11, 2003·64 cites·15 claims
- 0480US7309491B2Heat shock protein-based vaccines and immunotherapiesANTIGENICS INC·Filed 2004·Granted Dec 18, 2007·11 cites·47 claims
- 0580US7049302B1Compositions of CPG and saponin adjuvants and uses thereofANTIGENICS INC·Filed 1999·Granted May 23, 2006·47 cites·60 claims
- 0679US7030094B2Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21ANTIGENICS INC·Filed 2002·Granted Apr 18, 2006·20 cites·27 claims
- 0777US7420037B2Heat shock protein-based vaccines and immunotherapiesANTIGENICS INC·Filed 2004·Granted Sep 2, 2008·7 cites·45 claims
- 0863US7863434B2Characterization of granulocytic Ehrlichia and methods of useANTIGENICS INC·Filed 2001·Granted Jan 4, 2011·4 cites·29 claims
- 0950US2005191310A1Novel compositions of saponin adjuvants and excipientsANTIGENICS INC·Filed 2003·Application pending·0 cites
- 1049US2006210555A1Compositions comprising immunoreactive reagents and saponins, and methods of use thereofANTIGENICS INC·Filed 2002·Application pending·0 cites
- 1148US2004258705A1Use of lectins to promote oligomerization of glycoproteins and antigenic moleculesANTIGENICS INC·Filed 2004·Application pending·0 cites
- 1233US2007003555A1Heat shock protein binding fragments of CD91, and uses thereofANTIGENICS INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ANTIGENICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →